What test is used to visualize myocardial scar after a myocardial infarction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cardiac MRI with Late Gadolinium Enhancement (LGE-CMR)

Cardiac MRI with late gadolinium enhancement (LGE-CMR) is the reference standard test for visualizing myocardial scar after a myocardial infarction 1.

Why LGE-CMR is the Gold Standard

LGE-CMR provides near-histological precision for detecting and quantifying myocardial scar tissue with exceptional spatial resolution of approximately 1-2 mm 1. The technique works by administering gadolinium-based contrast agents that distribute into the extracellular space and accumulate in higher concentrations within fibrotic or infarcted myocardium. Images are acquired 10-15 minutes after contrast injection using inversion recovery sequences that selectively null signal in normal myocardium (appearing black) while scarred areas appear bright 1.

Key Technical Advantages

  • Superior spatial resolution: 1-2 mm in-plane resolution allows precise visualization of scar extent and transmurality 1
  • Quantitative assessment: Can measure both total scar volume and transmural extent (percentage of wall thickness involved) 1
  • No radiation exposure: Unlike nuclear imaging techniques 1
  • High prognostic value: Scar transmurality >50% predicts non-viable myocardium, while <25% transmurality indicates high probability of functional recovery after revascularization 1

Diagnostic Performance

LGE-CMR demonstrates 91% sensitivity and 51% specificity for predicting recovery of regional myocardial function 1. The specificity is particularly high (91%) for predicting absence of recovery, making it excellent for ruling out viable myocardium 1. The technique has been extensively validated against histopathology 1.

Alternative and Complementary Tests

While LGE-CMR is the reference standard, other modalities exist:

  • PET imaging with FDG: Shows 92% sensitivity and 68% specificity for viability assessment, particularly useful for detecting hibernating myocardium 1, but limited by availability, high cost, and radiation exposure (11 mSv) 1

  • SPECT imaging: Widely available but suffers from lower spatial resolution (10-15 mm) and relatively low specificity 1

  • Low-dose dobutamine stress echocardiography: Operator-dependent with limitations in patients with poor acoustic windows 1

  • Emerging techniques: Post-contrast T1 mapping and extracellular volume (ECV) quantification may supersede LGE in the future, offering more quantitative assessment 1

Important Clinical Caveats

Intermediate transmurality (25-75%) represents a diagnostic challenge where LGE sensitivity drops significantly 1. In these cases, adding low-dose dobutamine stress CMR improves accuracy for predicting functional recovery 1.

Contraindications to consider include severe renal failure (relative contraindication for gadolinium), claustrophobia, and non-MR compatible devices 1. In patients where gadolinium cannot be administered, native T1 mapping techniques show promise as contrast-free alternatives 1.

The test should be performed with standardized protocols using inversion recovery sequences, preferably with phase-sensitive inversion recovery pulses, acquiring images in multiple planes (short-axis stack and long-axis views) 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.